Page last updated: 2024-08-18

cyclohexanol and Diabetes Mellitus, Type 1

cyclohexanol has been researched along with Diabetes Mellitus, Type 1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, BL; Friedman, GC; Lim, AK; Ma, FY; Nikolic-Paterson, DJ; Ozols, E; Tesch, GH; Young, MJ1
Arguisola, MS; Tavakoli, SA1
Lithner, F1

Other Studies

3 other study(ies) available for cyclohexanol and Diabetes Mellitus, Type 1

ArticleYear
Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
    American journal of nephrology, 2011, Volume: 34, Issue:4

    Topics: Albuminuria; Animals; Blood Pressure; Body Weight; Cyclohexanols; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Early Medical Intervention; Hypertension; Hypertrophy; Immunohistochemistry; Inhibitory Concentration 50; Male; MAP Kinase Kinase 4; Protein Kinase Inhibitors; Purines; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction

2011
Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
    Southern medical journal, 2003, Volume: 96, Issue:7

    Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Interactions; Drug Therapy, Combination; Humans; Male; Obesity; Olanzapine; Pirenzepine; Risk Factors; Valproic Acid; Venlafaxine Hydrochloride

2003
Venlafaxine in treatment of severe painful peripheral diabetic neuropathy.
    Diabetes care, 2000, Volume: 23, Issue:11

    Topics: Adult; Cyclohexanols; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2000